Citadel Advisors’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-746,105
| Closed | -$37.4M | – | 8465 |
|
|
2016
Q4 | $32.5M | Buy |
746,105
+737,168
| +8,248% | +$29.7M | 0.03% | 584 |
|
|
2016
Q3 | $351K | Buy |
+8,937
| New | +$319K | ﹤0.01% | 5410 |
|
|
2016
Q2 | – | Sell |
-250,320
| Closed | -$7.04M | – | 7822 |
|
|
2016
Q1 | $6.8M | Sell |
250,320
-415,988
| -62% | -$9.81M | 0.01% | 1506 |
|
|
2015
Q4 | $19M | Buy |
666,308
+452,443
| +212% | +$14.3M | 0.02% | 869 |
|
|
2015
Q3 | $6.85M | Sell |
213,865
-238,282
| -53% | -$7.89M | 0.01% | 1631 |
|
|
2015
Q2 | $13.3M | Buy |
452,147
+383,930
| +563% | +$11.6M | 0.01% | 1276 |
|
|
2015
Q1 | $2.1M | Buy |
68,217
+40,284
| +144% | +$1.29M | ﹤0.01% | 3001 |
|
|
2014
Q4 | $780K | Sell |
27,933
-143,176
| -84% | -$3.73M | ﹤0.01% | 4098 |
|
|
2014
Q3 | $3.87M | Buy |
171,109
+165,381
| +2,887% | +$3.27M | ﹤0.01% | 2220 |
|
|
2014
Q2 | $87K | Sell |
5,728
-86,350
| -94% | -$1.48M | ﹤0.01% | 6343 |
|
|
2014
Q1 | $1.81M | Buy |
92,078
+53,359
| +138% | +$1.04M | ﹤0.01% | 2759 |
|
|
2013
Q4 | $732K | Buy |
38,719
+13,272
| +52% | +$190K | ﹤0.01% | 3552 |
|
|
2013
Q3 | $231K | Buy |
25,447
+10,253
| +67% | +$76.1K | ﹤0.01% | 4628 |
|
|
2013
Q2 | $97K | Buy |
+15,194
| New | +$72.2K | ﹤0.01% | 5251 |
|
Other funds holding ZLTQ
Citadel Advisors's ZLTQ Position: Q1 2017 in Review
Citadel Advisors sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q1 2017, closing a stake of 746,105 shares — an estimated $37.4M sold.
Citadel Advisors first reported a position in ZLTQ in Q2 2013 and held it in 14 quarters. The position peaked at $32.5M in Q4 2016. 194 funds tracked by Wall St. Rank hold ZLTQ as of Q1 2017.
- Citadel Advisors reported no remaining ZELTIQ Aesthetics, Inc. position as of Q1 2017 after selling out during the quarter.
- Citadel Advisors sold 746,105 ZELTIQ Aesthetics, Inc. shares in Q1 2017, an estimated $37.4M.
- Citadel Advisors first reported a position in ZELTIQ Aesthetics, Inc. in Q2 2013 and held it in 14 quarters.
- Citadel Advisors's ZELTIQ Aesthetics, Inc. position peaked at $32.5M in Q4 2016.
- 194 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q1 2017.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.